Get startedLog in
    Picture of Pharmicell Co logo

    005690 — Pharmicell Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pharmicell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line4,3475,2429,51310,8853,578
    Depreciation
    Amortisation
    Non-Cash Items-1,1402,743-14487.51,755
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-5,074-776-16,327-5,2433,640
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-75.58,978-5,2227,91411,814
    Capital Expenditures-1,124-559-4,304-18,949-6,016
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-530-3,046-5,041-1,58411,932
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Sale of Intangible Assets
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities-1,654-3,605-9,345-20,5325,916
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-145-17818,512-270-18,713
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1,8844,2345,272-11,853-635